PD-L1 and PIK3CA Testing Product Market Statistical Forecast, Trade Analysis 2024 - 2031

The PD-L1 and PIK3CA testing product market is anticipated to achieve a CAGR of 18.45% by 2031.

Will the PD-L1 and PIK3CA Testing Product market emerge as the sector's next great thing? To discover the answer, look at the PD-L1 and PIK3CA Testing Product market analysis and projections. In-depth insight of the opportunities, difficulties, and trends now impacting the Machinery landscape is provided by this market research study, empowering industry participants to make informed decisions in a changing environment. Take advantage of the opportunity in the PD-L1 and PIK3CA Testing Product market! (2031)

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/pd-l1-and-pik3ca-testing-product-market

PD-L1 and PIK3CA Testing Product Market Trends:

The market growth is expected to be driven by the increasing number of product launches by key players.

On December 15, 2020, Roche introduced the cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer. This in vitro diagnostic (IVD) test, previously available only for research use (RUO), is now approved in countries that recognize the CE mark. The cobas PIK3CA Mutation Test identifies 17 mutations in the PIK3CA gene, helping doctors determine which patients may benefit from PI3K-targeted therapies, as outlined by medical guidelines.

Segment Covered in the PD-L1 and PIK3CA Testing Product Market:

By Product Type: PD-L1, Cervical Cancer, Esophageal Cancer, NSCLC- Squamous, Squamous Cell Carcinoma of the Head and Neck, Triple-Negative Breast Cancer, Urothelial Carcinoma, PIK3CA

By End-User: Hospital, Diagnostic Center, Cancer Center, Others

Major Key players involved in PD-L1 and PIK3CA Testing Product Market
• F. Hoffmann-La Roche Ltd
• Agilent Technologies
• QIAGEN
• EntroGen, Inc.
• Amoy Diagnostics
• ACCB Biotech
• Myriad Genetic Laboratories, Inc.
• FOUNDATION MEDICINE

Product Portfolio:

cobas PIK3CA Mutation Test: The cobas PIK3CA Mutation Test (CE-IVD) is a real-time polymerase chain reaction (PCR) assay designed to detect PIK3CA mutations in tumors of patients with advanced or metastatic breast cancer.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/pd-l1-and-pik3ca-testing-product-market

Regional Analysis:
The global PD-L1 and PIK3CA Testing Product Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

The global PD-L1 and PIK3CA Testing Product Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The PD-L1 and PIK3CA Testing Product Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:
Pre-filled Flush Syringes Market: https://www.datamintelligence.com/research-report/pre-filled-flush-syringes-market

Urinalysis Testing Products Market: https://www.datamintelligence.com/research-report/urinalysis-testing-products-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.